Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different goserelin doses and timing in adenomyosis
ChiCTR2200059548Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jul 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of goserelin in adenomyosis (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Blood routine, Carbohydrate antigen-125 (CA125) and 4 more. Started Jul 2021; status: recruiting.
02
Drugs
goserelin
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR2200059548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059548.